chr15-98942702-T-A
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000875.5(IGF1R):c.3458-221T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.22 in 152,132 control chromosomes in the GnomAD database, including 4,596 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.22   (  4596   hom.,  cov: 33) 
Consequence
 IGF1R
NM_000875.5 intron
NM_000875.5 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  -0.161  
Publications
3 publications found 
Genes affected
 IGF1R  (HGNC:5465):  (insulin like growth factor 1 receptor) This receptor binds insulin-like growth factor with a high affinity. It has tyrosine kinase activity. The insulin-like growth factor I receptor plays a critical role in transformation events. Cleavage of the precursor generates alpha and beta subunits. It is highly overexpressed in most malignant tissues where it functions as an anti-apoptotic agent by enhancing cell survival. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, May 2014] 
IGF1R Gene-Disease associations (from GenCC):
- growth delay due to insulin-like growth factor I resistanceInheritance: AR, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9). 
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.38  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.220  AC: 33446AN: 152014Hom.:  4594  Cov.: 33 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
33446
AN: 
152014
Hom.: 
Cov.: 
33
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome   AF:  0.220  AC: 33458AN: 152132Hom.:  4596  Cov.: 33 AF XY:  0.222  AC XY: 16544AN XY: 74380 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
33458
AN: 
152132
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
16544
AN XY: 
74380
show subpopulations 
African (AFR) 
 AF: 
AC: 
15943
AN: 
41462
American (AMR) 
 AF: 
AC: 
3392
AN: 
15302
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
687
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
1640
AN: 
5172
South Asian (SAS) 
 AF: 
AC: 
974
AN: 
4820
European-Finnish (FIN) 
 AF: 
AC: 
1543
AN: 
10592
Middle Eastern (MID) 
 AF: 
AC: 
62
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
8663
AN: 
67990
Other (OTH) 
 AF: 
AC: 
443
AN: 
2116
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.502 
Heterozygous variant carriers
 0 
 1250 
 2500 
 3749 
 4999 
 6249 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 334 
 668 
 1002 
 1336 
 1670 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
862
AN: 
3478
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.